Biologic Therapy in Pediatric Chronic Rhinosinusitis: A Systematic Review
- 15 March 2024
- journal article
- review article
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 171 (1) , 35-44
Abstract
Objective: Provide clinicians with current evidence for biologic therapy in children with chronic rhinosinusitis with nasal polyposis (CRSwNP).Data Sources: PubMed, MEDLINE, Cochrane, and clinical trial registries.Review Methods: Key search terms related to biologic therapy in pediatric CRSwNP were identified via a structured query of current medical literature and clinical trial databases.Conclusions: There is a dearth of active clinical trials and research studies for biologics targeting pediatric CRSwNP. There is an ongoing compassionate‐use clinical trial involving Dupilumab for children with nasal polyps as well as only 1 published work specifically focused on Dupilumab for pediatric CRSwNP in the setting of aspirin‐exacerbated respiratory disease.Implications for Practice: For children with atopic dermatitis, asthma, and chronic idiopathic urticaria, biologic therapies such as Omalizumab, Dupilumab, and Mepolizumab have gained Food and Drug Administration approval. The role of biologic therapy in pediatric CRSwNP demonstrates significant promise in the comprehensive management of the unified airway. Additional Phase III trials are necessary to broaden clinical indications for children with comorbid conditions and complex sinonasal disease.Keywords
This publication has 59 references indexed in Scilit:
- Effect of an Intranasal Corticosteroid on Quality of Life and Local Microbiome in Young Children With Chronic RhinosinusitisJAMA Pediatrics, 2023
- Dupilumab Drug Survival and Associated Predictors in Patients With Moderate to Severe Atopic DermatitisJAMA Dermatology, 2022
- Histopathologic differences between adult and pediatric patients with chronic rhinosinusitisInternational Forum of Allergy & Rhinology, 2022
- The microbiome of pediatric patients with chronic rhinosinusitisInternational Forum of Allergy & Rhinology, 2020
- Cost Utility Analysis of Dupilumab Versus Endoscopic Sinus Surgery for Chronic Rhinosinusitis With Nasal PolypsThe Laryngoscope, 2020
- Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic DermatitisJAMA Dermatology, 2020
- Intranasal corticosteroids and saline: Usage and adherence in chronic rhinosinusitis patientsThe Laryngoscope, 2019
- Endoscopic sinus surgery for pediatric patients: Prognostic factors related to revision surgeryThe Laryngoscope, 2019
- Biofilm Surface Area in the Pediatric NasopharynxJAMA Otolaryngology–Head & Neck Surgery, 2007
- Adenoidectomy vs Endoscopic Sinus Surgery for the Treatment of Pediatric SinusitisJAMA Otolaryngology–Head & Neck Surgery, 1999